Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 10Recruiting 5Unknown 1Terminated 1No longer available 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Carcinoma, Renal Cell 12Kidney Neoplasms 5Neoplasms 3Neoplasm Metastasis 2Skin Neoplasms 1Radiation Therapy 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Clear-cell metastatic renal cell carcinoma 1Carcinoma 1

Interventions

pembrolizumab 6cabozantinib 6Nivolumab 5Ipilimumab 5Axitinib 5Radiosurgery 3Blood Specimen Collection 3zimberelimab 2lenvatinib 2Ultrasonography 2Radiotherapy 2Biopsy 2tislelizumab 1polyethylene glycol 3350 1pazopanib 1palbociclib 1orellanine 1olaparib 1gallium Ga 68 dotatate 1fludarabine 1cyclopropapyrroloindole 1brodalumab 1belzutifan 1atezolizumab 1anlotinib 1adagrasib 1Watchful Waiting 1Vincristine 1Therapeutics 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Kidney Neoplasms × Axitinib × Clear all
NCT07227415 2026-06-04

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Pfizer

Phase 1/2 Recruiting
224 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT05969496 2026-04-13

NEOPAX

University of Colorado, Denver

Phase 2 Recruiting
17 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07123090 2026-03-25

SPARCC

Dana-Farber Cancer Institute

Phase 2 Recruiting
25 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06962787 2025-11-17

A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Recruiting
260 enrolled
Genitourinary

Kidney Neoplasms

NCT06364631 2025-01-16

CARE1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
1,250 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔